Literature DB >> 4880147

Urinary hydroxyproline excretion in patients with juvenile rheuatoid arthritis, with and without corticosteroid therapy.

M Smith, B M Ansell, E G Bywaters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4880147     DOI： 10.1016/s0022-3476(68)80240-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  6 in total

1.  Effect of ascorbic acid on urinary hydroxyproline in children receiving corticosteroids.

Authors:  D Liakakos; D G Ikkos; P Vlachos; K Ntalles; C Coulouris
Journal:  Arch Dis Child       Date:  1977-10       Impact factor: 3.791

Review 2.  Hydroxyprolinuria in normal Zairean children.

Authors:  I Mubay; J M Mbuyi-Muamba; R Kalala-Lunganza; J Dequeker
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

3.  Corticotrophin therapy in juvenile chronic polyarthritis (Still's disease) and effect on growth.

Authors:  D W Zutshi; M Friedman; B M Ansell
Journal:  Arch Dis Child       Date:  1971-10       Impact factor: 3.791

4.  Hydroxyproline excretion in various forms of growth failure.

Authors:  W M Teller; U Genscher; H Burkhardt; K Rommel
Journal:  Arch Dis Child       Date:  1973-02       Impact factor: 3.791

5.  Effect of ascorbic acid on urinary hydroxyproline of children receiving corticosteroids.

Authors:  P Saphykhajon; B J Grossman; J Quinn
Journal:  Arch Dis Child       Date:  1977-01       Impact factor: 3.791

6.  Metabolism of collagen in aspartylglycosaminuria: urinary excretion of hydroxyproline.

Authors:  K Näntö-Salonen; S Autio; E Härö; T Kivimäki; S L Koskela; V Näntö; R Penttinen
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.